Regeneron

New Sanofi/Regeneron Drug Leads To Dramatic Reductions In Bad Cholesterol
Forbes
Thu, 11/10/11 - 01:45 pm
Sanofi
Regeneron
RGN727
LDL cholesterol
Lipitor
November Catalysts for Biotech and Drug Stocks
Minyanville
Mon, 10/31/11 - 11:34 am
FDA
Regeneron
Vertex
Pharmasset
pSivida
Alimera
Salix
Teva Pharmaceuticals
BioSante
Transcept
1 Biotech To Buy And 6 FDA Decision-Pending Biotechs To Avoid
Seeking Alpha
Fri, 10/28/11 - 11:07 am
Celgene
Pacira
Incyte
BioSante
Regeneron
Transcept
Antares
Regeneron 3Q loss widens as expenses climb
MSNBC
Thu, 10/27/11 - 04:11 pm
Regeneron
earnings
7 FDA Decisions You Can't Afford to Ignore in Q4
Motley Fool
Sat, 10/15/11 - 11:39 am
Bristol-Myers Squibb
Dapagliflozin
BioSante
Bio-T-Gel
Regeneron
Eylea
Transcept
Intermezzo
Incyte
ruxolitinib
Antares
Anturol
Regeneron Soars on Eye-Drug Rival Setback
TheStreet.com
Wed, 09/21/11 - 11:24 pm
Regeneron
Roche
Avastin
wet-AMD
age-related macular degeneration
Regeneron Pharmaceuticals Shares Plunged: What You Need to Know
Motley Fool
Sat, 09/10/11 - 09:55 am
Regeneron
Eylea
age-related macular degeneration
FDA Approval Process Sets Higher Bar For What's Treatable
Seeking Alpha
Thu, 09/8/11 - 11:12 am
FDA
AstraZeneca
JNJ
Perrigo Company
Regeneron
generics
Biotech Busts And Breakthroughs For August
Forbes
Thu, 09/1/11 - 11:34 am
Mako Surgical
Luminex
Regeneron
Pharmasset
ViroPharma
Dendreon
Pacific Biosciences
ZOLL Medical
Savient
Human Genome Sciences
Next big drug against cholesterol takes shape
HealthNews
Sat, 08/27/11 - 01:35 pm
Regeneron
Sanofi
hypercholesterolemia
PCSK9
Amgen
Merck
Alnylam
Bristol-Myers Squibb
REGN727
Biotech Stocks Pains Continue As Outflows Persist
Forbes
Mon, 08/22/11 - 11:59 am
Biomarin
Regeneron
Spectrum
Regeneron: A Poke in the Eye From the FDA
Motley Fool
Fri, 08/19/11 - 09:05 am
Regeneron
FDA
Eyelea
macular degeneration
Regeneron Says FDA Delays Eylea Drug for Blindness
Bloomberg
Wed, 08/17/11 - 08:27 am
Regeneron
FDA
blindness
Eylea
Lucentis
Roche
The Next Big Thing in Biotech: Regeneron Pharmaceuticals (video)
The Street
Sun, 08/14/11 - 11:27 am
Regeneron
Biotech Calendar: 2011-12 FDA Drug Approvals
TheStreet.com
Thu, 08/11/11 - 12:37 pm
biotech
drug approvals
FDA
Eyelea
Regeneron
Dendreon
Provenge
NuPathe
Zelrix
Adcetris
Seattle Genetics
Soliris
Alexion
Dapagliflozin
AstraZeneca
Bristol-Myers Squibb
EXPAREL
Pacira
Roche
Zelboraf
Iluvien
Alimera
Bio-T-Gel
Teva Pharmaceuticals
BioSante
Zevalin
Spectrum
ruxolitinib
Incyte
Novartis
Pfizer
crizotinib
Antares
Anturol
Bydureon
Amlyin
Eli Lilly
Alkermes
AZ-004
Alexza
Corlux
Corcept Therapeutics
Affymax
Takeda
peginesatide
Levadex
MAP Pharmaceuticals
Dendreon's Blowup Spreads Across Biotech
TheStreet.com
Thu, 08/4/11 - 10:57 am
Dendreon
Provenge
InterMune
Human Genome Sciences
Seattle Genetics
Regeneron
Savient
Biotech Calendar: Key Dates for August
TheStreet.com
Tue, 08/2/11 - 12:29 pm
Alexa
Gilead Sciences
Regeneron
Dendreon
NuPathe
Provenge
Adcetris
Seattle Genetics
Eyelea
Btripla
Zelrix
AZ-004
5 Healthcare Companies With August Catalysts
Seeking Alpha
Sun, 07/31/11 - 10:20 am
Regeneron
Shire
NuPathe
Seattle Genetics
Gilead Sciences
3 Biotech Stocks Predictive Analysts Expect to Outperform
Seeking Alpha
Mon, 07/25/11 - 09:41 am
Immunogen
InterMune
Regeneron
Regeneron Pharmaceuticals Earnings Preview
Motley Fool
Sat, 07/23/11 - 04:27 pm
Regeneron
earnings

Pages